Kratom week in review, 19-25 September 2026: the Ole Miss deaths, and Colorado makes lab testing a court-enforced obligation

The week of 19 to 25 September 2026 was driven by a US story with no confirmed cause and heavy coverage: the deaths of two University of Mississippi students, with kratom packaging recovered at both scenes. Around it, Colorado turned its kratom statute into a signed settlement carrying testing and record-keeping obligations, US treatment providers published fresh patient figures, and the Massachusetts prohibition entered its legislative phase. For anyone buying at volume, the thread running through all four is documentation: what is in the lot, and who can evidence it.

Two Ole Miss deaths put substance identification at the centre of the story

Two University of Mississippi students, Aidan Hamilton and Robert Strang, were found dead in separate locations on Monday 21 September. The Associated Press reported on 24 September that Lafayette County Metro Narcotics recovered kratom packaging during the investigation and that the product had come from a retail store, while stressing that investigators had no confirmed information that kratom played a role in either death and no evidence connecting the two cases. Toxicology is being expedited by state agencies.

The American Kratom Association issued condolences on 23 September and asked that quantitative toxicology distinguish naturally occurring mitragynine from concentrated or synthesised 7-hydroxymitragynine before conclusions are drawn; it then held a press conference on 25 September on the coverage. Separately, WBRC reported that Alabama, where kratom has been banned since 2016, has executed dozens of search warrants and seized thousands of doses this year.

Why it matters to the trade: general coverage rarely separates botanical leaf from concentrated 7-OH preparations, and buyers should expect retailer and end-customer questions that treat the two as one category. The useful answer is a document. Fresh Kratom Thai produces roasted ground leaf powder and standardised mitragynine extract in Bang Len District, Nakhon Pathom, and in Sisaket Province on GMP-standard equipment, and its products have been analysed by the Thailand Institute of Scientific and Technological Research (TISTR) for mitragynine content.

Update, 28 September. The position has moved since this briefing’s window closed. Mississippi Public Safety Commissioner Sean Tindell told Fox News on 25 September that toxicology reports were expected as early as this week, and that Parker’s Law, the state’s 2022 fentanyl-delivery statute, could apply if the investigation supports it. On 27 September the American Kratom Association asked Lafayette County Sheriff Joey East to identify the recovered products by brand, manufacturer and lot number, to laboratory-test their contents against their labelling, and to confirm whether they are being tested for the synthetic opioid cychlorphine. Kratom has been prohibited by county ordinance in Lafayette County since 2021.

Colorado turns its kratom act into a signed testing and record-keeping obligation

On 21 September the Colorado Attorney General’s office announced a settlement with Sahansila Karki and Gokul Tiwari, owners of the wholesaler DNB Distro and 15 retail stores trading as Million Smoke N Vape, over kratom products the state says exceeded the legal potency limit and lacked required labelling and packaging. The owners agreed to pay 152,000 US dollars, face a further 500,000 dollar penalty if they breach the terms, and must test all kratom products for compliance and retain invoices documenting every third-party kratom purchase.

The statute behind it is Senate Bill 25-072, the Daniel Bregger Act, which caps 7-hydroxymitragynine at 2 per cent of a product’s alkaloid fraction, sets a 21-and-over age limit and requires specified disclosures on the label. The Kratom Consumer Advisory Council, convened by the Global Kratom Coalition, welcomed the enforcement action on 24 September; its chair, Dr C. Michael White, said natural kratom leaf, conventional extracts and highly concentrated 7-OH products differ materially in composition and risk.

Why it matters to the trade: the obligation runs upstream. A retailer required to hold purchase documentation and test against a percentage-of-alkaloids standard needs a supplier who issues that paperwork as routine. FKT’s TISTR analysis covers mitragynine content alongside vitamins, minerals and 18 amino acids, and is available to buyers who must now keep it on file.

US treatment providers report a sharp rise in kratom and 7-OH patients

STAT reported on 21 September that US addiction treatment providers are seeing rapid growth in kratom and 7-OH patients. Boulder Care, a telehealth provider, said kratom patients rose from 3 per cent of new patients in September 2025 to 8 per cent in July 2026 and 14 per cent in August 2026, and that close to a third of its new buprenorphine patients reported current kratom or 7-OH use. Recovery Centers of America in Massachusetts reported moving from roughly one such patient a week to between 10 and 20. HealthDay carried the same clinic figures on 22 September. The clinicians quoted draw a consistent line between high-concentration 7-OH formulations and conventional leaf powder, which carries 7-OH only in trace amounts.

Why it matters to the trade: these figures will be read into state hearings through the winter sessions, and are already shaping how legislators frame the category. For brand manufacturers the consequence is commercial rather than clinical: formulating to a stated alkaloid specification, rather than to a marketing claim, is becoming a condition of market access. That is the basis on which FKT sells.

Massachusetts: a one-year clock on a statewide Schedule I order

Massachusetts classified all forms of kratom as Schedule I by emergency order of its Public Health Commissioner, issued at Governor Healey’s direction and effective 28 August 2026, for a period of up to one year, covering powders, tablets, capsules, gummies and dissolvable strips. Writing on 25 September, the Harvard Crimson reported that 35 municipalities had regulated or banned kratom before the state order and 14 more acted after it, and set out the competing bills before the legislature: one, filed by Representative Colleen Garry, would make kratom a Class A controlled substance; a rival would ban synthetic 7-OH while regulating natural leaf through labelling and a 21-and-over limit.

Why it matters to the trade: Massachusetts is closed for the next year, and whichever bill prevails will be read elsewhere as a template, either blanket prohibition or a statutory split between leaf and concentrate. If the split model spreads, demand moves toward material with documented alkaloid composition and a traceable origin. That is the segment FKT supplies out of Thailand.

Wholesale enquiries

Fresh Kratom Thai supplies standardised mitragynine extract and roasted ground leaf powder to international wholesale buyers and brand manufacturers, produced in Nakhon Pathom and Sisaket on GMP-standard equipment and analysed by TISTR. For specifications, availability and pricing, write to freshkratomthai@gmail.com.

This briefing reports regulatory, enforcement and industry developments for trade readers. It is not legal advice and makes no claim about the effects of any product. Regulatory status differs by jurisdiction and changes frequently.